Adobe

FDA advisory panel narrowly rejects compounding of one peptide, backs another

The votes bring health secretary RFK Jr. one step closer to his mission of making these unapproved compounds more available for Americans.

By Lizzy Lawrence

Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak

As health secretary Kennedy promotes more fruit and vegetable consumption, his agencies have cut back on monitoring food-borne illnesses. That's a problem.

By Susan Mayne

STAT+ | White House offers its science blueprint: More AI, less life sciences

Report by Trump science adviser Michael Kratsios, called 'Science: A New Golden Age,' prioritizes industry over academia.

By Anil Oza

Annie Rice/AP

There are already more U.S. measles cases this year than in all of 2025

Latest CDC update reports 2,318 cases of measles, with vast majority involving unvaccinated people. Vaccination rate now below key protection threshold.

By Associated Press

Opinion: I may be one of the last middle-class medical students who could afford to become a doctor

Federal student loan changes will keep many students from medical school, just as physician shortages become more acute.

By Gauri Gurumurthy

STAT+ | Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill

The timing of the announcement is notable because Merck is striking these deals while its HIV pill is currently undergoing two late-stage trials.

By Ed Silverman

Joe Raedle/Getty Images

Senate advances MAHA-friendly bill for food warning labels and junk food ad bans

Bill to ban junk food ads targeted to children and require FDA warning labels on ultra-processed foods clears Senate committee with bipartisan support.

By Sarah Todd

Opinion: The U.S. pharmaceutical supply chain problem is not about China

The root cause of U.S. pharmaceuticals supply chain vulnerabilities is inadequate regulation of an industry that tends to prioritize profit.

By Pooja Yerramilli